Cargando…

Statin use and risk of progression to liver cirrhosis in chronic hepatitis B independent of conventional risk factors: A nationwide study

Many studies have elucidated the protective associations of statin use with liver cancer or mortality, but studies examining statin's effect on the risk of progression to liver cirrhosis considering medical/metabolic conditions or lifestyle factors are lacking. We aimed to assess statin's...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yun, Byungyoon, Ahn, Sang Hoon, Yoon, Jin‐Ha, Kim, Beom Kyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426396/ https://www.ncbi.nlm.nih.gov/pubmed/35766457 http://dx.doi.org/10.1002/hep4.2022

Ejemplares similares

Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study
por: Yun, Byungyoon, et al.
Publicado: (2022)

Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials
por: Kraglund, Frederik, et al.
Publicado: (2023)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Does severe subacute noise exposure increase risk of new onset hypertension beyond conventional risk factors? A 30 000 person-years cohort study
por: Yun, Byungyoon, et al.
Publicado: (2022)

Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis
por: Shin, Seunghwan, et al.
Publicado: (2022)

Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status
por: Kim, Mi Na, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression
por: Lee, Hankil, et al.
Publicado: (2021)

Amiodarone and risk of liver cirrhosis: a nationwide, population-based study
por: Huang, Ching-Hui, et al.
Publicado: (2019)

Prevalence of Statin Use and Predictors of Statin Initiation Among Patients with Alcohol-Related Cirrhosis - A Danish Nationwide Cohort Study
por: Ramsing, Marine Sølling, et al.
Publicado: (2023)

Acute Variceal Hemorrhage in Patients with Liver Cirrhosis: Weekend versus Weekday Admissions
por: Byun, Sun Jeong, et al.
Publicado: (2012)

CLIF–SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis
por: Jeong, Jin Hee, et al.
Publicado: (2016)

Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
por: An, Jihyun, et al.
Publicado: (2022)

The significant association between quick return and depressive symptoms and sleep disturbances in paid workers: A nationwide survey
por: Yun, Byungyoon, et al.
Publicado: (2022)

Statins and the risk of cirrhosis in hepatitis B or C patients: a systematic review and dose-response meta-analysis of observational studies
por: Wang, Yaqin, et al.
Publicado: (2017)

Adiponectin Provides Additional Information to Conventional Cardiovascular Risk Factors for Assessing the Risk of Atherosclerosis in Both Genders
por: Yoon, Jin-Ha, et al.
Publicado: (2013)

Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008–2011)
por: Hong, Kyung Soo, et al.
Publicado: (2020)

Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
por: Lee, Jae Seung, et al.
Publicado: (2022)

No Increased Risk for Primary Osteoarthritis in Liver Cirrhosis – A Danish Nationwide Cohort Study
por: Deleuran, Thomas, et al.
Publicado: (2016)

Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
por: Park, Jihye, et al.
Publicado: (2017)

Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance
por: Yoon, Jun Sik, et al.
Publicado: (2020)

Comprehensive evaluation of effects and safety of statin on the progression of liver cirrhosis: a systematic review and meta-analysis
por: Gu, Yue, et al.
Publicado: (2019)

Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
por: Shin, Haneulsaem, et al.
Publicado: (2019)

Multicenter Retrospective Risk Assessment of Esophageal Variceal Bleeding in Patients with Cirrhosis: An Acoustic Radiation Force Impulse Elastography-Based Prediction Model
por: Heo, Ja Yoon, et al.
Publicado: (2019)

Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis
por: Li, Xu, et al.
Publicado: (2019)

Risk of progression of Barrett's esophagus in patients with cirrhosis
por: Apfel, Tehilla, et al.
Publicado: (2017)

Risk and adverse outcomes of fractures in patients with liver cirrhosis: two nationwide retrospective cohort studies
por: Chen, Ta-Liang, et al.
Publicado: (2017)

Use of statins and risk of glioma: a nationwide case–control study in Denmark
por: Gaist, D, et al.
Publicado: (2013)

Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study
por: Nguyen, Cu Dinh, et al.
Publicado: (2013)

Statin use and risk of nonmelanoma skin cancer: a nationwide study in Denmark
por: Arnspang, S, et al.
Publicado: (2015)

Statin use and risk of contralateral breast cancer: a nationwide cohort study
por: Langballe, Rikke, et al.
Publicado: (2018)

The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver Cirrhosis
por: Chung, Goh-Eun, et al.
Publicado: (2021)

Involvement of Ornithine Carbamoyltransferase in the Progression of Chronic Hepatitis C and Liver Cirrhosis
por: Ohnishi, Masahiko, et al.
Publicado: (2017)

Statin use and risk for ovarian cancer: a Danish nationwide case–control study
por: Baandrup, L, et al.
Publicado: (2015)

Risk of rheumatoid arthritis diagnosis in statin users in a large nationwide US study
por: Peterson, Madeline N., et al.
Publicado: (2021)

Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study
por: Tuyet Kristensen, Daniel, et al.
Publicado: (2023)

Chinese herbal medicine therapy and the risk of mortality for chronic hepatitis B patients with concurrent liver cirrhosis: a nationwide population-based cohort study
por: Tsai, Tzung-Yi, et al.
Publicado: (2018)

Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
por: Kim, Seung Up, et al.
Publicado: (2016)

Spontaneous Bacterial Peritonitis in Patients with Hepatitis B Virus-Related Liver Cirrhosis: Community-Acquired versus Nosocomial
por: Kim, Seung Up, et al.
Publicado: (2012)

Follow-Up Liver Stiffness Measurements after Liver Resection Influence Oncologic Outcomes of Hepatitis-B-Associated Hepatocellular Carcinoma with Liver Cirrhosis
por: Lee, Jung Il, et al.
Publicado: (2019)

Hepatic adenomatosis in liver cirrhosis
por: Gordic, Sonja, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ptdekci36c7476ine0f6id17fp